Breast cancer therapy(Polar NanoPharma SL)

N/A

Report date: 2026/01/14 09:25:41
NME

Base Information

Drug NameBreast cancer therapy(Polar NanoPharma SL)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPolar NanoPharma SL
China Registration ClassN/A

Develop Information

Active CompaniesPolar NanoPharma SL
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A